[DPHARMA] YoY Cumulative Quarter Result on 30-Jun-2024 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
15-Aug-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2024
Quarter
30-Jun-2024 [#2]
Profit Trend
QoQ- 109.24%
YoY- -9.12%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 411,292 367,991 367,683 321,893 302,044 295,852 257,250 8.12%
PBT 42,061 44,805 48,119 43,373 37,118 37,102 26,170 8.22%
Tax -10,095 -9,633 -11,517 -10,369 -8,828 -8,721 -5,184 11.73%
NP 31,966 35,172 36,602 33,004 28,290 28,381 20,986 7.25%
-
NP to SH 31,966 35,172 36,602 33,004 28,290 28,381 20,986 7.25%
-
Tax Rate 24.00% 21.50% 23.93% 23.91% 23.78% 23.51% 19.81% -
Total Cost 379,326 332,819 331,081 288,889 273,754 267,471 236,264 8.20%
-
Net Worth 692,598 670,448 634,375 614,350 581,725 503,029 209,983 21.98%
Dividend
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Div 9,619 4,788 4,734 3,530 3,421 6,618 4,199 14.80%
Div Payout % 30.09% 13.62% 12.93% 10.70% 12.10% 23.32% 20.01% -
Equity
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Net Worth 692,598 670,448 634,375 614,350 581,725 503,029 209,983 21.98%
NOSH 961,942 961,942 952,239 706,330 684,383 661,881 650,902 6.72%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 7.77% 9.56% 9.95% 10.25% 9.37% 9.59% 8.16% -
ROE 4.62% 5.25% 5.77% 5.37% 4.86% 5.64% 9.99% -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
RPS 42.76 38.42 38.83 45.58 44.13 44.70 91.88 -11.95%
EPS 3.32 3.68 3.88 4.67 4.13 4.26 3.22 0.51%
DPS 1.00 0.50 0.50 0.50 0.50 1.00 1.50 -6.52%
NAPS 0.72 0.70 0.67 0.87 0.85 0.76 0.75 -0.67%
Adjusted Per Share Value based on latest NOSH - 961,942
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
RPS 42.76 38.25 38.22 33.46 31.40 30.76 26.74 8.13%
EPS 3.32 3.66 3.81 3.43 2.94 2.95 2.18 7.25%
DPS 1.00 0.50 0.49 0.37 0.36 0.69 0.44 14.64%
NAPS 0.72 0.697 0.6595 0.6387 0.6047 0.5229 0.2183 21.98%
Price Multiplier on Financial Quarter End Date
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Date 28/06/24 30/06/23 30/06/22 30/06/21 30/06/20 28/06/19 29/06/18 -
Price 1.26 1.30 1.20 3.03 1.62 1.37 1.30 -
P/RPS 2.95 3.38 3.09 6.65 3.67 3.06 1.41 13.07%
P/EPS 37.92 35.40 31.04 64.83 39.19 31.95 17.34 13.91%
EY 2.64 2.82 3.22 1.54 2.55 3.13 5.77 -12.20%
DY 0.79 0.38 0.42 0.17 0.31 0.73 1.15 -6.06%
P/NAPS 1.75 1.86 1.79 3.48 1.91 1.80 1.73 0.19%
Price Multiplier on Announcement Date
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Date 15/08/24 24/08/23 16/08/22 17/08/21 13/08/20 30/08/19 26/11/18 -
Price 1.17 1.19 1.34 2.49 3.15 1.41 1.08 -
P/RPS 2.74 3.10 3.45 5.46 7.14 3.15 1.18 15.05%
P/EPS 35.21 32.41 34.66 53.28 76.20 32.88 14.41 16.04%
EY 2.84 3.09 2.88 1.88 1.31 3.04 6.94 -13.82%
DY 0.85 0.42 0.37 0.20 0.16 0.71 1.39 -7.86%
P/NAPS 1.62 1.70 2.00 2.86 3.71 1.86 1.44 1.98%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment